A commonly used medication, fluconazole, used to treat vaginal yeast infections, is linked to higher rates of miscarriage if used during pregnancy, found new research published in CMAJ (Canadian Medical...

In a follow-up on the Dengvaxia situation in the Philippines, the Food and Drug Administration (FDA) reports permanently revoking the Certificates of Product Registration (CPR) of dengue vaccine Dengvaxia...

Novartis announced this week the approval of Egaten® (triclabendazole) by the US Food and Drug Administration (FDA) for the treatment of fascioliasis in patients six years of age and older. Egaten is...

Newborns infected with herpes simplex virus (HSV) can be appropriately treated with acyclovir, a drug typically prescribed to adults for the treatment of HSV infections. Acyclovir’s drug label now includes...

Merck announced this week that the U.S. Food and Drug Administration (FDA) has accepted for review regulatory filings for two antibacterial agents. These filings are: (1) a NDA accepted for Priority Review...

Australian company, Mayne Pharma announced this week that their antifungal drug, TOLSURA™ (SUBA®-itraconazole) 65mg capsule, will be launched in the United States. TOLSURA is a new formulation of...

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet. Eighteen healthy adults...

Biopharmaceutical company focused on developing new antibiotics for difficult-to-treat bacterial infections, Acurx Pharmaceuticals announced today that the U.S. Food and Drug Administration has granted...

There is a new medication that in one dose successfully protected nonhuman primates against a lethal infection of all strains of the deadly Ebola virus. The findings are now available in Cell Host &...

Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and...